3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
3
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Dermatologic
3
Conditions
Carcinoma, Basal Cell
3
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Basal Cell
1
Neoplasm Metastasis
1
Melanoma
1
Medulloblastoma
1
Lung Neoplasms
1
Eyelid Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
Nivolumab
7
cemiplimab
6
Specimen Handling
5
HhAntag691
5
Radiotherapy
4
Magnetic Resonance Spectroscopy
4
Ipilimumab
4
Biopsy
4
sonidegib
3
pembrolizumab
3
CTLA-4 Antigen
3
relatlimab
2
prednylidene
2
deltacortene
2
daromun
2
Surgical Procedures, Operative
2
Standard of Care
2
Prednisone
2
Observation
2
Aminolevulinic Acid
2
tocilizumab
1
talimogene laherparepvec
1
poly ICLC
1
flt3 ligand protein
1
X-Rays
1
Watchful Waiting
1
Vitamin D
1
Tomography, Optical Coherence
1
Therapeutics
1
Tacrolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Carcinoma, Basal Cell
×
sonidegib
×
1 year
×
Clear all
NCT04066504
2026-03-18
NISSO
Sun Pharmaceutical Industries Limited
Completed
323 enrolled
NCT03534947
2025-12-16
SONIB
Melanoma Institute Australia
Phase 2
Completed
16 enrolled
NCT07068568
2025-07-16
BCC-Sonidegib
Federico II University
Completed
12 enrolled